◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
Immuno-Biological Laboratories Co.,Ltd. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemQ4 2025Nov 14, 2025Q4 2024Nov 14, 2024Q1 2024Mar 31, 2024Q1 2023Mar 31, 2023Q1 2022Mar 31, 2022
+Operating Income 68.0M 13.3M -- -- --
Operating Margin % 105.9% 43.4% -- -- --
+Ordinary Income 64.2M 30.6M -- -- --
Revenue Growth % 109.6% -- -- -- --
Line ItemQ4 2025Nov 14, 2025Q4 2024Nov 14, 2024Q1 2024Mar 31, 2024Q1 2023Mar 31, 2023Q1 2022Mar 31, 2022
Current Assets 1.4B 1.3B -- -- --
Total Assets 1.8B 1.6B 1.4B 1.6B 1.7B
Current Liabilities 281.3M 257.8M -- -- --
Total Liabilities 331.0M 353.3M 328.9M 340.1M 331.8M
Total Equity 1.5B 1.3B 1.1B 1.3B 1.4B
Equity Ratio -- -- 0.77 0.79 0.81
No data available for this statement.
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...